Join Dr. Mike Stone and Dr. Mike Mallin as they explore a recent study on the potential of Precision Medicine to lower Alzheimer's risk for those with ApoE4. The doctors delve into the impact of oxidative stress, insulin resistance, and inflammation on Alzheimer's risk and how precision, lifestyle interventions may be the key in prevention. Throughout the episode, the doctors highlight the importance of personalized treatment plans for individuals with ApoE4, and the potential of Precision Medicine to guide these plans. The doctors discuss how Precision Medicine, which tailors treatments to an individual's unique genetic makeup, can offer a more targeted approach to prevention. Tune in to learn how Precision Medicine can play a critical role in prevention of Alzheimer's disease for those with ApoE4. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073598/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related